Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00

S. Rusakiewicz, S. Tyekucheva, S. Tissot-Renaud, K. Chaba, M. Imbimbo, F. Benedetti, R. Kammler, J. Hornfeld, E. Munzone, L. Gianni, B. Thurlimann, I. Láng, G. Pruneri, K.P. Gray, M.R. Regan, S. Loi, M. Colleoni, G. Viale, L. Kandalaft, G. Coukos, Giuseppe Curigliano

Open source

DOI: 10.1016/j.ejca.2024.113535
Published: 2024-03
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2024.113535,
  title = {Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00},
  author = {S. Rusakiewicz and S. Tyekucheva and S. Tissot-Renaud and K. Chaba and M. Imbimbo and F. Benedetti and R. Kammler and J. Hornfeld and E. Munzone and L. Gianni and B. Thurlimann and I. Láng and G. Pruneri and K.P. Gray and M.R. Regan and S. Loi and M. Colleoni and G. Viale and L. Kandalaft and G. Coukos and Giuseppe Curigliano},
  year = {2024},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2024.113535},
  url = {https://doi.org/10.1016/j.ejca.2024.113535}
}

RIS

TY  - JOUR
TI  - Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
AU  - S. Rusakiewicz
AU  - S. Tyekucheva
AU  - S. Tissot-Renaud
AU  - K. Chaba
AU  - M. Imbimbo
AU  - F. Benedetti
AU  - R. Kammler
AU  - J. Hornfeld
AU  - E. Munzone
AU  - L. Gianni
AU  - B. Thurlimann
AU  - I. Láng
AU  - G. Pruneri
AU  - K.P. Gray
AU  - M.R. Regan
AU  - S. Loi
AU  - M. Colleoni
AU  - G. Viale
AU  - L. Kandalaft
AU  - G. Coukos
AU  - Giuseppe Curigliano
PY  - 2024
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2024.113535
UR  - https://doi.org/10.1016/j.ejca.2024.113535
ER  -

APA

Rusakiewicz, S., Tyekucheva, S., Tissot-Renaud, S., Chaba, K., Imbimbo, M., Benedetti, F., Kammler, R., Hornfeld, J., Munzone, E., Gianni, L., Thurlimann, B., Láng, I., Pruneri, G., Gray, K., Regan, M., Loi, S., Colleoni, M., Viale, G., Kandalaft, L., Coukos, G., & Curigliano, G. (2024). Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.113535

Source records

crossref · retrieved 2026-09-25T11:07:03.836Z